SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DR. BOND who wrote (870)11/23/1997 9:54:00 PM
From: Anaxagoras  Read Replies (1) of 7041
 
<<Why hasn't the ANALYST AT VOLPE Publicly Supported Zona during all this controversy?>>

Jeeze, you step away for a few days and all heck breaks loose.

Bond, I haven't verified this, but I believe s/he has. On the conference call I believe that one participant mentioned that on the 17th of November a Volpe analyst had released an updated report on Schering mentioning that SGP was an "accumulate" based on the prospects of their recent deal with ZONA. Note, I am reporting what I believe I heard and I have not verified this information; I am merely reporting what I believe I heard.

It is however disappointing that they haven't been more aggressive in their support- likewise with SGP.

Golly, I don't even own any of this stock yet, but there sure is a lot of misinformation out there; frightening stuff, these threads.

Anaxagoras
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext